These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 39063241)

  • 1. Opioid Use and Gut Dysbiosis in Cancer Pain Patients.
    Coluzzi F; Scerpa MS; Loffredo C; Borro M; Pergolizzi JV; LeQuang JA; Alessandri E; Simmaco M; Rocco M
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the Use of Peripherally Acting μ-Opioid Receptor Antagonists (PAMORAs) in Oncologic Patients: from Scientific Evidence to Real Clinical Practice.
    Fernández-Montes A; de Velasco G; Aguín S; Farriols C; Guirado-Risueño M; Jerviz-Guía VG; Baeza-Nadal MV; Chicas-Sett R; Fírvida JL; García-Navalón F; Martín P; Perezagua-Marín C; Rodríguez D; Santamaría J; Saurí T; Cobo M
    Curr Treat Options Oncol; 2021 Feb; 22(3):26. PubMed ID: 33635493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the Current and Possible Future Use of Opioid Antagonists in Relation to Opioid-Induced Constipation and Dysbiosis.
    Essmat N; Karádi DÁ; Zádor F; Király K; Fürst S; Al-Khrasani M
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bidirectional relationship between opioids and the gut microbiome: Implications for opioid tolerance and clinical interventions.
    Taboun ZS; Sadeghi J
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111142. PubMed ID: 37918085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications.
    Streicher JM; Bilsky EJ
    J Pharm Pract; 2018 Dec; 31(6):658-669. PubMed ID: 28946783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of opioid-induced constipation in pregnancy: a concise review with emphasis on the PAMORAs.
    Li Z; Pergolizzi JV; Huttner RP; Zampogna G; Breve F; Raffa RB
    J Clin Pharm Ther; 2015 Dec; 40(6):615-9. PubMed ID: 26573866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "Culture" of Pain Control: A Review of Opioid-Induced Dysbiosis (OID) in Antinociceptive Tolerance.
    Mischel RA; Muchhala KH; Dewey WL; Akbarali HI
    J Pain; 2020; 21(7-8):751-762. PubMed ID: 31841668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid system influences gut-brain axis: Dysbiosis and related alterations.
    Rueda-Ruzafa L; Cruz F; Cardona D; Hone AJ; Molina-Torres G; Sánchez-Labraca N; Roman P
    Pharmacol Res; 2020 Sep; 159():104928. PubMed ID: 32504837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Opioid-Induced Constipation in Patients with Cancer Pain].
    Aruga E
    Gan To Kagaku Ryoho; 2021 Nov; 48(11):1311-1315. PubMed ID: 34795117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripherally Acting μ-Opioid Receptor Antagonists in the Management of Postoperative Ileus: a Clinical Review.
    Chamie K; Golla V; Lenis AT; Lec PM; Rahman S; Viscusi ER
    J Gastrointest Surg; 2021 Jan; 25(1):293-302. PubMed ID: 32779081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the Role of Peripheral Sensory and Gut Mu Opioid Receptors: Peripheral Analgesia and Tolerance.
    Fürst S; Zádori ZS; Zádor F; Király K; Balogh M; László SB; Hutka B; Mohammadzadeh A; Calabrese C; Galambos AR; Riba P; Romualdi P; Benyhe S; Timár J; Schmidhammer H; Spetea M; Al-Khrasani M
    Molecules; 2020 May; 25(11):. PubMed ID: 32466522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gut microbiota mediates reward and sensory responses associated with regimen-selective morphine dependence.
    Lee K; Vuong HE; Nusbaum DJ; Hsiao EY; Evans CJ; Taylor AMW
    Neuropsychopharmacology; 2018 Dec; 43(13):2606-2614. PubMed ID: 30258112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid-Induced Constipation in Oncological Patients: New Strategies of Management.
    Mesía R; Virizuela Echaburu JA; Gómez J; Sauri T; Serrano G; Pujol E
    Curr Treat Options Oncol; 2019 Dec; 20(12):91. PubMed ID: 31853656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delphi consensus on strategies in the management of opioid-induced constipation in cancer patients.
    Sarrió RG; Calsina-Berna A; García AG; Esparza-Miñana JM; Ferrer EF; ; Porta-Sales J
    BMC Palliat Care; 2021 Jan; 20(1):1. PubMed ID: 33388041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of morphine- and fentanyl-induced impairment of intestinal epithelial antibacterial activity in dysbiosis and its impact on the microbiota-gut-brain axis.
    Muchhala KH; Kallurkar PS; Kang M; Koseli E; Poklis JL; Xu Q; Dewey WL; Fettweis JM; Jimenez NR; Akbarali HI
    FASEB J; 2024 Apr; 38(8):e23603. PubMed ID: 38648368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights on efficacious doses of PAMORAs for patients on chronic opioid therapy or opioid-naïve patients.
    van Malderen K; Halawi H; Camilleri M
    Neurogastroenterol Motil; 2018 May; 30(5):e13250. PubMed ID: 29119706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Peripherally Acting μ-Opioid Receptor Antagonist (PAMORAs) for the Management of Patients With Opioid-Induced Constipation: A Systematic Review.
    Rekatsina M; Paladini A; Drewes AM; Ayob F; Viswanath O; Urits I; Corli O; Pergolizzi J; Varrassi G
    Cureus; 2021 Jul; 13(7):e16201. PubMed ID: 34367804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of oxycodone/naloxone in the management of patients with pain and opioid-induced constipation.
    Leppert W; Zajaczkowska R; Wordliczek J
    Expert Opin Pharmacother; 2019 Apr; 20(5):511-522. PubMed ID: 30625013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid-induced dysbiosis of maternal gut microbiota during gestation alters offspring gut microbiota and pain sensitivity.
    Abu YF; Singh S; Tao J; Chupikova I; Singh P; Meng J; Roy S
    Gut Microbes; 2024; 16(1):2292224. PubMed ID: 38108125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meeting the challenges of opioid-induced constipation in chronic pain management - a novel approach.
    Reimer K; Hopp M; Zenz M; Maier C; Holzer P; Mikus G; Bosse B; Smith K; Buschmann-Kramm C; Leyendecker P
    Pharmacology; 2009; 83(1):10-7. PubMed ID: 18957874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.